Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001567619-23-006604
Filing Date
2023-07-17
Accepted
2023-07-17 11:07:49
Documents
1
Group Members
BRADEN M LEONARD

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G 81066
  Complete submission text file 0001567619-23-006604.txt   82693
Mailing Address 156 S. FIRST STREET ZIONSVILLE IN 46077
Business Address 156 S. FIRST STREET ZIONSVILLE IN 46077 317-344-6689
BML Investment Partners, L.P. (Filed by) CIK: 0001373604 (see all company filings)

IRS No.: 383708345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 1250 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Subject) CIK: 0001662774 (see all company filings)

IRS No.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91007 | Film No.: 231090860
SIC: 2836 Biological Products, (No Diagnostic Substances)